# 2025-04028: Drug Trafficker and Fraudster Gets 10-Year U.S. Ban.

2025-04028, Harpreet Singh: Final Debarment Order, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2025-03-13, effective 2025-03-13; PRIA reads it as touching household money (as of 2026-09-30).

- Canonical: https://policyrisk.com/federal-register/2025-04028
- As of: 2026-09-30
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-04028
- Title: Harpreet Singh: Final Debarment Order
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 11986
- Published: 2025-03-13
- Effective: 2025-03-13
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-09-30

## In one line

Drug Trafficker and Fraudster Gets 10-Year U.S. Ban.

## Summary

Harpreet Singh is banned for 10 years from importing any drugs into the U.S. because he was convicted of serious crimes like drug trafficking and fraud. He didn’t respond to the FDA’s notice, so the ban starts on March 13, 2025. Singh can apply to end this ban anytime, but it won’t be easy or quick.

## Abstract

The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Harpreet Singh for a period of 10 years from importing or offering for import any drug into the United States. FDA bases this order on a finding Mr. Singh was convicted of multiple felony offenses, which serve as the basis for this debarment, that are conspiracy to possess with intent to distribute cathinone, tapentadol, tramadol, and carisoprodol; one felony count under Federal law for fraudulent importation and transportation of goods; one felony count under Federal law for conspiracy to launder money; and one felony count under Federal law for conspiracy to obstruct justice. The factual basis supporting Mr. Singh's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Singh was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of November 20, 2024 (30 days after receipt of the notice), Mr. Singh had not responded. Mr. Singh's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

## Effects PRIA read

- 10‑Year Import Ban for Harpreet Singh: cost, high. Harpreet Singh is debarred for 10 years from importing or offering for import any drug into the United States, effective March 13, 2025. The debarment is based on his May 21, 2024 felony convictions for offenses including conspiracy to possess with intent to distribute several controlled substances…
- Prohibition on Acting with or Directing Singh: cost, medium. Beginning March 13, 2025, under section 301(cc) of the FD&C Act it is a prohibited act to import or offer for import any drug 'by, with the assistance of, or at the direction of' Harpreet Singh. Businesses or individuals cannot lawfully rely on Mr. Singh to import drugs without risking a prohibited…
- Right to Apply to End Debarment; Public Filing Rules: mixed, low. Mr. Singh may submit an application to terminate his debarment at any time under section 306(d)(1) of the FD&C Act. Applications submitted electronically to https://www.regulations.gov will be posted publicly unchanged, while confidential information can be submitted only as a written/paper submiss…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-04028 on federalregister.gov](https://www.federalregister.gov/documents/2025/03/13/2025-04028/harpreet-singh-final-debarment-order)
- [2025-04028 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-03-13/pdf/2025-04028.pdf)

## Related
- [Previous: 2025-04027, Atlantic Highly Migratory Species; Schedules for Atlantic Shark Identification…](https://policyrisk.com/federal-register/2025-04027)
- [Next: 2025-04029, Alnashir Alibhai Punjani: Final Debarment Order](https://policyrisk.com/federal-register/2025-04029)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-04028 (as of 2026-09-30).
